|
|
||||||||
1 Laboratoire de Physiologie Cellulaire, Institut National de la Santé et de la Recherche Médicale (INSERM) EPI-9938, 3 Laboratoire de Biologie du Développement, and 8 Laboratoire de Neuroendocrinologie du Développement, Université des Sciences et Technologies de Lille, 59655 Villeneuve d'Ascq; 2 Service d'Anatomo-pathologie, Centre Hospitalier de Roubaix, 59056 Roubaix; 4 Laboratoire de Neuroendocrinologie et de Physiopathologie neuronale, INSERM U422, 59045 Lille; 5 Laboratoire Pierre Fabre, La Chartreuse, and 6 Laboratoire Pierre Fabre Médicaments, 81106 Castres; and 7 Université Pierre et Marie Curie, 75006 Paris, France
The effects of the polypeptide hormone
prolactin (PRL) in the development and regulation of benign prostate
hyperplasia (BPH) and also in prostate cancer are not very well
characterized. This study examines the action of PRL, either alone or
in association with androgens [testosterone (T) or dihydrotestosterone
(DHT)], in the rat prostate gland. The effects of PRL and androgens
were investigated after 30 and 60 days in control, castrated, castrated with a substitutive implant of T or DHT, and sham-operated Wistar rats.
To enhance PRL release, we induced hyperprolactinemia by administering
chronic injections of sulpiride (40 mg · kg
1 · day
1). Chronic
hyperprolactinemia induces enlargement and inflammation of the lateral
rat prostate without any histological changes on ventral and dorsal
lobes. We also demonstrate that hyperprolactinemia induces Bcl-2
overexpression in the lateral rat prostate and that this could inhibit
the level of apoptosis. The in vivo model established here is a useful
in vivo approach for studying the hormonal regulation of normal and
pathological prostate development.
prolactin; testosterone; dihydrotestosterone
This article has been cited by other articles:
![]() |
P. W. Harvey, D. J. Everett, and C. J. Springall Adverse effects of prolactin in rodents and humans: breast and prostate cancer J Psychopharmacol, March 1, 2008; 22(2_suppl): 20 - 27. [Abstract] [PDF] |
||||
![]() |
X. Zhang, Z. Zhang, W. Cheng, X. Mou, and G. P. Reynolds The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat J Psychopharmacol, June 1, 2007; 21(4): 428 - 434. [Abstract] [PDF] |
||||
![]() |
P W Harvey, D J Everett, and C J Springall Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer Human and Experimental Toxicology, July 1, 2006; 25(7): 395 - 404. [Abstract] [PDF] |
||||
![]() |
N Berteaux, S Lottin, E Adriaenssens, F Van Coppenolle, X Leroy, J Coll, T Dugimont, and J-J Curgy Hormonal regulation of H19 gene expression in prostate epithelial cells J. Endocrinol., October 1, 2004; 183(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Yu-Lee Prolactin Modulation of Immune and Inflammatory Responses Recent Prog. Horm. Res., January 1, 2002; 57(1): 435 - 455. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |